MAPK7 and acute myeloid leukemia: ERK5 can compensate for targeting ERK1/2 to inhibit upregulation of macrophage colony stimulating factor receptor (M-CSFR)-mediated macrophage differentiation in acute myeloid leukemia cells [1,4].